Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma.
about
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cellsCytoplasmic poly(A) binding protein C4 serves a critical role in erythroid differentiationEvaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinomaFundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.Statistical use of argonaute expression and RISC assembly in microRNA target identificationRoles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinomaMatrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formationEvaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern ChinaA global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels.Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.Multiset Statistics for Gene Set Analysis.Nasopharyngeal carcinoma: molecular biomarker discovery and progress.Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasisDistinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area.A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci.GWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseasesHLA associations with nasopharyngeal carcinoma.FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblastsFunctional genomics as a tool in virus research.Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinomaExpression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosisThe progress on genetic analysis of nasopharyngeal carcinoma.Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin.Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinomaOverexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor PrognosisDecreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinomaGene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.Identification of genes involved in Epstein-Barr virus-associated nasopharyngeal carcinomaGlutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma.PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survivalGenome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.Proof for EBV's sustaining role in Burkitt's lymphomas.Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems.
P2860
Q27863380-40B4B1A9-CA6E-48BC-AD90-67B47D739875Q28483778-7514ADFE-B70B-4634-AF77-A52B636F8667Q28589228-5BE53DA7-E846-4BC0-95C4-E114E6687AFFQ31083741-3FF01ACC-4435-4A5F-9DE4-E6A94B6DD320Q33285000-EFA44E28-238B-40A2-AF3C-DDC181C5F11CQ33506607-410800E2-CA84-4901-A6B0-303612C01E4FQ33688934-EE200769-C020-473B-B6B6-D55EE1654EC7Q33889053-AC92BB8B-D6F8-4AB2-A40C-CC17F5BB495CQ34056327-83265C32-71CC-49DD-B822-E5AE9537D2AEQ34081186-ACA7EF92-2DC5-4F09-87B8-BB436FE4264DQ34345591-2EBCF7CC-0A26-4D8A-ACBF-77ECEBE41618Q34507851-79604065-C4F1-4DFC-BB10-16F036A8006FQ35140295-57D3BDBA-4CEC-498A-9775-C7A45FE59A96Q35191816-B22A31AB-1050-4252-9ADB-E1CED3614873Q35511501-FCCB5444-26CF-435E-B216-3BBFEA8FEF4FQ35597559-12D1A90B-BAB2-44AF-8486-8186C7FE8CD6Q35677629-C7C42194-F217-44B3-B584-697474350937Q35795725-50BC1493-F410-46AD-91BA-D670B9E0E690Q35808018-A747E652-78D8-4C93-921F-C477A7658DF9Q35826481-46241800-6EE4-4F57-8743-985A8C092294Q35885173-82CE1F49-DABC-4E5A-A476-8EC1827C0731Q36053844-BBED7B29-DADE-4710-8002-CADB8C207359Q36125265-C1489DC5-5D98-4B58-A508-DF09A7D3434AQ36164237-47197686-6FD3-4A77-B301-B0B0990605F1Q36207171-E5ED619B-03EB-404D-BCD9-131FAE43C6EFQ36256160-2573C461-FCA4-4F5D-B98A-E2A49F76B39CQ36299700-A3F7B605-4D3D-4B04-BF19-92B2E3250719Q36338606-9D1807F8-B732-469C-A6EF-8E09FE8D3D21Q36445020-20BD7C6F-07AC-48FB-9133-2D67F5B36505Q36540111-373823B5-7D57-4F1B-889D-064F088DE6C2Q36742929-473E832E-C985-4616-B721-6D8DA94D2385Q37015716-8F54EC44-638E-4299-9F54-CE7F74695BA9Q37117769-3FC7193D-3589-4A2C-86E2-6C6FDB5A0D7BQ37240280-896F4772-15A5-4792-BBC0-139528784053Q37289393-C38B7632-53E8-4F7C-93E7-A3D51F4204CBQ37290566-59D7596D-76B9-41BC-A48E-80C685BC8857Q37295736-075E9F5E-9599-4B35-9B78-0675591F1988Q37301260-79CBD624-5DE1-4850-9F75-6744ED693CC7Q37463625-E239EAC6-FBC8-4FF9-8499-B54FAC208E6BQ37534984-41BB4B98-EED5-4039-86F1-CDDF50A51F33
P2860
Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@ast
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@en
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@nl
type
label
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@ast
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@en
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@nl
prefLabel
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@ast
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@en
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@nl
P2093
P1433
P1476
Genome-wide expression profili ...... n in nasopharyngeal carcinoma.
@en
P2093
Bill Sugden
Chien-Jen Chen
David B Dahl
I-How Chen
Johan A den Boon
Michael A Newton
Paul Ahlquist
Srikumar Sengupta
William H Westra
P304
P356
10.1158/0008-5472.CAN-05-4399
P407
P577
2006-08-01T00:00:00Z